Congress Cost-effectiveness of Bezlotoxumab for the prevention of recurrence of clostridium difficile infection in high risk patients in Spain Authors: Cobo J, Grau S, Pascual A, Aragón B, Maratia S, Jiang Y, Molloy B, Aceituno S, Salavert M Year: 2018 Congress: ECCMID 2018 - European Congress of Clinical Microbiology and Infectious Diseases